Skip to main content
Top
Published in: Annals of Surgical Oncology 11/2016

01-10-2016 | Gynecologic Oncology

Factors Impacting Use of Robotic Surgery for Treatment of Endometrial Cancer in the United States

Published in: Annals of Surgical Oncology | Issue 11/2016

Login to get access

Abstract

Objective

This study was designed to examine the impact of patient socioeconomic, clinical, and hospital characteristics on the utilization of robotics in the surgical staging of endometrial cancer.

Methods

Patients surgically treated for endometrial cancer at facilities that offered robotic and open approaches were identified from the National Inpatient Sample Database from 2008 to 2012. The groups were compared for socioeconomic, clinical, and hospital differences. Medical comorbidity scores were calculated using the Charlson comorbidity index. T tests and χ 2 were used to compare groups. Multivariable analyses were used to determine factors that were independently associated with a robotic approach.

Results

A total of 18,284 patients were included (robotic, n = 7169; laparotomy, n = 11,115). Significant differences were noted in all patient clinical and socioeconomic characteristics and all hospital characteristics. Multivariable analyses identified factors that independently predicted patients undergoing robotic surgery. These patients were older [adjusted odds ratio (aOR) 1.008; 95 % confidence interval (CI) 1.004–1.011], white (aOR 1.38; 95 % CI 1.27–1.50), and privately insured (aOR 1.16; 95 % CI 1.07–1.26). Clinically, these women were more likely to be obese (aOR 1.20; 95 % CI 1.11–1.30) and to be undergoing an elective case (aOR 1.25; 95 % CI 1.11–1.40). Hospitals were more likely to be under private control (aOR 1.55, 95 % CI 1.39–1.71) but less likely to be located in the south (aOR 0.87; 0.81–0.93), quantified as large or medium (aOR 0.57; 95 %CI 0.50–0.67), or teaching hospitals (aOR 0.68; 95 % CI 0.63–0.74).

Conclusions

Socioeconomic status and hospital characteristics are factors that independently predict robotic utilization in the United States. These racial, socioeconomic, and geographic disparities warrant further study regarding the utilization of this important technology.
Literature
1.
2.
go back to reference DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, Kramer JL, et al. Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin. 2014;64(4):252–71.CrossRefPubMed
3.
go back to reference Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6.CrossRefPubMed Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94(7):490–6.CrossRefPubMed
4.
go back to reference Morris AM, Rhoads KF, Stain SC, Birkmeyer JD. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg. 2010;211(1):105–13.CrossRefPubMed Morris AM, Rhoads KF, Stain SC, Birkmeyer JD. Understanding racial disparities in cancer treatment and outcomes. J Am Coll Surg. 2010;211(1):105–13.CrossRefPubMed
5.
go back to reference Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMed Shavers VL, Brown ML. Racial and ethnic disparities in the receipt of cancer treatment. J Natl Cancer Inst. 2002;94(5):334–57.CrossRefPubMed
6.
go back to reference Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106–13.CrossRefPubMed Bach PB, Schrag D, Brawley OW, Galaznik A, Yakren S, Begg CB. Survival of blacks and whites after a cancer diagnosis. JAMA. 2002;287(16):2106–13.CrossRefPubMed
7.
go back to reference Parsons HM, Habermann EB, Stain SC, Vickers SM, Al-Refaie WB. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals? J Am Coll Surg. 2012;214(4):539–47; discussion 47–9. CrossRefPubMed Parsons HM, Habermann EB, Stain SC, Vickers SM, Al-Refaie WB. What happens to racial and ethnic minorities after cancer surgery at American College of Surgeons National Surgical Quality Improvement Program hospitals? J Am Coll Surg. 2012;214(4):539–47; discussion 479. CrossRefPubMed
8.
go back to reference Liu FW, Randall LM, Tewari KS, Bristow RE. Racial disparities and patterns of ovarian cancer surgical care in California. Gynecol Oncol. 2014;132(1):221–6.CrossRefPubMed Liu FW, Randall LM, Tewari KS, Bristow RE. Racial disparities and patterns of ovarian cancer surgical care in California. Gynecol Oncol. 2014;132(1):221–6.CrossRefPubMed
9.
go back to reference Aranda MA, McGory M, Sekeris E, Maggard M, Ko C, Zingmond DS. Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer? Gynecol Oncol. 2008;111(2):166–72.CrossRefPubMedPubMedCentral Aranda MA, McGory M, Sekeris E, Maggard M, Ko C, Zingmond DS. Do racial/ethnic disparities exist in the utilization of high-volume surgeons for women with ovarian cancer? Gynecol Oncol. 2008;111(2):166–72.CrossRefPubMedPubMedCentral
10.
go back to reference Robinson CN, Balentine CJ, Sansgiry S, Berger DH. Disparities in the use of minimally invasive surgery for colorectal disease. J Gastrointest Surg. 2012;16(5):897–903; discussion -4.CrossRefPubMed Robinson CN, Balentine CJ, Sansgiry S, Berger DH. Disparities in the use of minimally invasive surgery for colorectal disease. J Gastrointest Surg. 2012;16(5):897–903; discussion -4.CrossRefPubMed
11.
go back to reference Loehrer AP, Song Z, Auchincloss HG, Hutter MM. Massachusetts health care reform and reduced racial disparities in minimally invasive surgery. JAMA Surg. 2013;148(12):1116–22.CrossRefPubMedPubMedCentral Loehrer AP, Song Z, Auchincloss HG, Hutter MM. Massachusetts health care reform and reduced racial disparities in minimally invasive surgery. JAMA Surg. 2013;148(12):1116–22.CrossRefPubMedPubMedCentral
12.
go back to reference Varela JE, Nguyen NT. Disparities in access to basic laparoscopic surgery at U.S. academic medical centers. Surg Endosc. 2011;25(4):1209–14.CrossRefPubMed Varela JE, Nguyen NT. Disparities in access to basic laparoscopic surgery at U.S. academic medical centers. Surg Endosc. 2011;25(4):1209–14.CrossRefPubMed
14.
go back to reference Koh W-Jea. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines):Uterine Neoplasms. National Cancer Center Network; Version 2.2015. Koh W-Jea. NCCN Clinical Practice Guidelines in Oncology (NCCN guidelines):Uterine Neoplasms. National Cancer Center Network; Version 2.2015.
15.
go back to reference Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009;27(32):5331–6.CrossRefPubMedPubMedCentral Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Laparoscopy compared with laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group Study LAP2. J Clin Oncol. 2009;27(32):5331–6.CrossRefPubMedPubMedCentral
16.
go back to reference Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30(7):695–700.CrossRefPubMedPubMedCentral Walker JL, Piedmonte MR, Spirtos NM, Eisenkop SM, Schlaerth JB, Mannel RS, et al. Recurrence and survival after random assignment to laparoscopy versus laparotomy for comprehensive surgical staging of uterine cancer: Gynecologic Oncology Group LAP2 Study. J Clin Oncol. 2012;30(7):695–700.CrossRefPubMedPubMedCentral
17.
go back to reference Sinno AK, Fader AN. Robotic-assisted surgery in gynecologic oncology. Fertil Steril. 2014;102(4):922–32.CrossRefPubMed Sinno AK, Fader AN. Robotic-assisted surgery in gynecologic oncology. Fertil Steril. 2014;102(4):922–32.CrossRefPubMed
18.
go back to reference Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Gynecol Oncol. 2008;111(1):41–5.CrossRefPubMed Gehrig PA, Cantrell LA, Shafer A, Abaid LN, Mendivil A, Boggess JF. What is the optimal minimally invasive surgical procedure for endometrial cancer staging in the obese and morbidly obese woman? Gynecol Oncol. 2008;111(1):41–5.CrossRefPubMed
19.
go back to reference Doo DW, Guntupalli SR, Corr BR, Sheeder J, Davidson SA, Behbakht K, et al. Comparative surgical outcomes for endometrial cancer patients 65 years old or older staged with robotics or laparotomy. Ann Surg Oncol. 2015;22(11):3687–3694.CrossRefPubMed Doo DW, Guntupalli SR, Corr BR, Sheeder J, Davidson SA, Behbakht K, et al. Comparative surgical outcomes for endometrial cancer patients 65 years old or older staged with robotics or laparotomy. Ann Surg Oncol. 2015;22(11):3687–3694.CrossRefPubMed
20.
go back to reference Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Jr., Brooks RA, et al. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013;107(6):653–8.CrossRefPubMed Yu X, Lum D, Kiet TK, Fuh KC, Orr J, Jr., Brooks RA, et al. Utilization of and charges for robotic versus laparoscopic versus open surgery for endometrial cancer. J Surg Oncol. 2013;107(6):653–8.CrossRefPubMed
24.
go back to reference Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83.CrossRefPubMed Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chron Dis. 1987;40(5):373–83.CrossRefPubMed
25.
go back to reference Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–9.CrossRefPubMed
26.
go back to reference Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol. 2013;130(3):652–9.CrossRefPubMedPubMedCentral Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol. 2013;130(3):652–9.CrossRefPubMedPubMedCentral
27.
go back to reference Fedewa SA, Lerro C, Chase D, Ward EM. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol. 2011;122:63–8.CrossRefPubMed Fedewa SA, Lerro C, Chase D, Ward EM. Insurance status and racial differences in uterine cancer survival: a study of patients in the National Cancer Database. Gynecol Oncol. 2011;122:63–8.CrossRefPubMed
28.
go back to reference Liang MI, Rosen MA, Rath KS, Hade EM, Clements AE, Backes FJ, et al. Predicting inpatient stay lasting two midnights or more after robotic surgery for endometrial cancer. J Minim Invasive Gynecol. 2015;22(4):583–589.CrossRefPubMed Liang MI, Rosen MA, Rath KS, Hade EM, Clements AE, Backes FJ, et al. Predicting inpatient stay lasting two midnights or more after robotic surgery for endometrial cancer. J Minim Invasive Gynecol. 2015;22(4):583–589.CrossRefPubMed
29.
go back to reference Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133(2):353–61.CrossRefPubMedPubMedCentral Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol. 2014;133(2):353–61.CrossRefPubMedPubMedCentral
30.
go back to reference Chan JK, Gardner AB, Taylor K, Blansit K, Thompson CA, Brooks R, et al. The centralization of robotic surgery in high-volume centers for endometrial cancer patients: a study of 6560 cases in the U.S. Gynecol Oncol. 2015;138(1):128–32.CrossRefPubMed Chan JK, Gardner AB, Taylor K, Blansit K, Thompson CA, Brooks R, et al. The centralization of robotic surgery in high-volume centers for endometrial cancer patients: a study of 6560 cases in the U.S. Gynecol Oncol. 2015;138(1):128–32.CrossRefPubMed
31.
go back to reference Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol. 2008;111:407–11.CrossRefPubMed Bell MC, Torgerson J, Seshadri-Kreaden U, Suttle AW, Hunt S. Comparison of outcomes and cost for endometrial cancer staging via traditional laparotomy, standard laparoscopy and robotic techniques. Gynecol Oncol. 2008;111:407–11.CrossRefPubMed
Metadata
Title
Factors Impacting Use of Robotic Surgery for Treatment of Endometrial Cancer in the United States
Publication date
01-10-2016
Published in
Annals of Surgical Oncology / Issue 11/2016
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-016-5252-x

Other articles of this Issue 11/2016

Annals of Surgical Oncology 11/2016 Go to the issue